News
HHS' decision "could stagnate research that has the potential to save millions of lives," writes Simon Williams.
A multi-institutional team led by Weill Cornell Medicine has received a five-year, $14.9 million grant from the National ...
Targeted vaccines and antiviral prophylaxis are expanding prevention options and redefining ‘safe sex’ for gay, bisexual and other men who have sex with men.
A potential breakthrough in the ongoing AIDS crisis could be deprioritized due to the decisions of noted vaccine skeptic Robert F. Kennedy, Jr.
In the wake of a fatal shooting at the headquarters of the Centers for Disease Control and Prevention (CDC) in Atlanta on ...
The answer is tuberculosis. And it kills more than 3,400 people across the globe every day—nearly 1.3 million in 2023 ...
Kenya is one of nine African countries selected for the initial rollout of lenacapavir (LEN), a new injectable drug for human ...
Unit 371 at Illinois Masonic Hospital was a major treatment center for AIDS and inspired similar wards in Chicago and across ...
Thousands of Kenyans are set to benefit from the roll-out of Lenacapavir injectable HIV preventive drug. The drug is the ...
Access is the central tenet to the success of lenacapavir as a form of preexposure prophylaxis (PrEP), according to Jeremiah Johnson, the executive director of PrEP4All and Mitchell Warren, the ...
The government has canceled nearly $500 million in research grants into the revolutionary technology, which experts believe ...
After decades of strong federal support for scientific research, the US government is now proposing deep cuts. Here’s what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results